Estimates and trends of the global burden of NASH-related liver cancer attributable to high fasting plasma glucose in 1990-2019: analysis of data from the 2019 Global Burden of Disease Study.
Ziyi LiNa YangLiyun HeJialu WangFan PingWei LiLingling XuHuabing ZhangYu-Xiu LiPublished in: Diabetology & metabolic syndrome (2023)
The burden of NASH-related liver cancer attributable to HFPG has increased over the past three decades, particularly in regions with high and low SDI.